51 related articles for article (PubMed ID: 19520774)
1. In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.
Chen Y; Liu L; Laille E; Kumar G; Surapaneni S
Cancer Chemother Pharmacol; 2010 Apr; 65(5):995-1000. PubMed ID: 20119716
[TBL] [Abstract][Full Text] [Related]
2.
Wright KM; Magana AA; Laethem RM; Moseley CL; Banks TT; Maier CS; Stevens JF; Quinn JF; Soumyanath A
Drug Metab Dispos; 2020 Oct; 48(10):1053-1063. PubMed ID: 32581050
[No Abstract] [Full Text] [Related]
3. Lack of CYP3A4 protein induction despite mRNA induction in primary hepatocytes exposed to rifabutin as a possible explanation for its low interaction risk in vivo.
Nilles J; Theile D; Weiss J; Haefeli WE; Ruez S
Arch Toxicol; 2024 May; ():. PubMed ID: 38713375
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions.
Martin P; Czerwiński M; Limaye PB; Muranjan S; Ogilvie BW; Smith S; Boyd B
Pharmacol Res Perspect; 2022 Jun; 10(3):e00958. PubMed ID: 35599345
[TBL] [Abstract][Full Text] [Related]
5. Metabolite Profiling in Anticancer Drug Development: A Systematic Review.
Muhamad N; Na-Bangchang K
Drug Des Devel Ther; 2020; 14():1401-1444. PubMed ID: 32308372
[TBL] [Abstract][Full Text] [Related]
6. Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats.
Nassar AF; Wisnewski A; King I
Xenobiotica; 2015; 45(8):711-21. PubMed ID: 25798740
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation and Rearrangement of Laromustine.
Nassar AE; Wisnewski AV; King I
Drug Metab Dispos; 2016 Aug; 44(8):1349-63. PubMed ID: 27278961
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
Robertson P; DeCory HH; Madan A; Parkinson A
Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
[TBL] [Abstract][Full Text] [Related]
9. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.
Zhou D; Andersson TB; Grimm SW
Drug Metab Dispos; 2011 Apr; 39(4):703-10. PubMed ID: 21177984
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
[TBL] [Abstract][Full Text] [Related]
13. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
